March 17, 2015
4:00 pm to 5:00 pm EDT

Sponsored by

Webinar Description:

Symposium will provide a detailed overview of sample identification and quality control with the MassARRAY® System utilizing the iPLEX Pro Sample ID Panel. In addition, we will highlight why the MassARRAY® System was selected to screen paired tumor and germline specimens submitted to The Cancer Genome Atlas (TCGA).

Learning Objectives:

• Agena Bioscience's MassARRAY System provides a high-throughput and low cost solution for establishing sample identity and quality.
• This sample identification method can be utilized by bio-banks and bio repositories to ensure sample identity and quality in their collections.
• The MassARRAY System and iPlex® Pro Sample ID Panel have been successfully used to screen tumor and germline specimens submitted to The Cancer Genome Atlas (TCGA).

Who should attend:

• Director- Core Labs, Bio-banks
• Scientist/ Technologist- R&D
• Professor- R&D Academic running core labs
• Director/ Staff Scientist/ Pathologist- Hospital, Clinics- Sample collection labs

Speakers:

Erik Zmuda, PhD.
Screening Paired Tumor and Germline Specimens Submitted to The Cancer Genome Atlas (TCGA) Using a Customized Sample ID Panel on the MassARRAY System.

Technical Director of the Biospecimen Core Resource Molecular Laboratory
Nationwide Children’s Hospital, Columbus, Ohio, USA

Erik Zmuda is an American Board of Medical Genetics and Genomics Fellow in Clinical Molecular Genetics who also currently works as a Molecular Genetics Technical Director in the Department of Pathology and Laboratory Medicine at Nationwide Children’s Hospital (NCH) in Columbus, Ohio. He completed his Ph.D. in Molecular, Cellular and Developmental Biology in 2009 at the Ohio State University (OSU), prior to working as a post-doc in an academic lab at OSU and subsequently the pharmaceutical industry (Regeneron Inc.). For the past four years he has directed operations in the molecular laboratory for The Cancer Genome Atlas Biospecimen Core Resource (TCGA-BCR) in the Research Institute at NCH.

Darryl Irwin, PhD.
High-Throughput Sample Identification and Quality Control with the MassARRAY System from Agena Bioscience.

Director – Applications and Technology
Agena Bioscience

Dr Darryl Irwin is the Director – Applications and Technology for Agena Bioscience where he manages the scientific operations in the Asia Pacific region including customer support, genetic services, marketing and product development activities. Darryl’s PhD from the University of Queensland was focused on developing techniques for non-invasive prenatal genetic testing. Darryl has previously worked in various roles include clinical immunology test development, clinical genetic testing and core laboratory genotyping suite manager.

Cost: No cost!

Schedule conflict? Register and you'll receive a copy of the recording!